(Q57274795)

Heli Nevanlinna

10

0 references

Carl Blomqvist

8

Carl Blomqvist

0 references

Olli-Pekka Kallioniemi

9

Olli-Pekka Kallioniemi

0 references

Hannaleena Eerola

4

Hannaleena Eerola

0 references

Karl von Smitten

6

Karl von Smitten

0 references

Pia Vahteristo

1

Pia Vahteristo

0 references

Kirsi Syrjäkoski

2

Kirsi Syrjäkoski

0 references

Kaija Holli

7

Kaija Holli

0 references

Kristiina Aittomäki

5

European Journal of Human Genetics

Kristiina Aittomäki

0 references

publication date

7 December 2005

0 references

published in

0 references

volume

14

0 references

issue

2

0 references

page(s)

167-172

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/sj.ejhg.5201542

0 references

cites work

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

CHEK2 variant I157T may be associated with increased breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Identification of a RING protein that can interact in vivo with the BRCA1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

The BARD1-CstF-50 interaction links mRNA 3' end formation to DNA damage and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Mutational analysis of BARD1 in familial breast cancer patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Familial breast cancer in southern Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

inferred from DOI database lookup

7 January 2021

based on heuristic

The future of association studies of common cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542

inferred from DOI database lookup

7 January 2021

based on heuristic

Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201542